Since the beginning of this year, there have been rumors in the market that Genscript Bio planned to sell Legend Biotech (LEGN.NS), but so far, the rumors have not materialized. In the morning of October 22, Genscript issued a statement stating that Legend Biotech's financial performance will no longer be consolidated into the company's financial statements. Genscript's Chief Financial Officer and Vice President of Investor Relations, Wei Shinui, responded to reporters, stating that recently, Legend Biotech and the custodian bank have reinitiated discussions and decided to terminate the aforementioned deposit agreement. Therefore, Genscript's voting rights over Legend Biotech have decreased from over 50% to below 50%. According to Hong Kong Financial Reporting Standards, Legend Biotech's financial data can no longer be included in Genscript's financial statements. Is Legend Biotech seeking a sale? In response to this, Wei Shinui stated that the company currently has no further information to disclose externally. (Yicai)